Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

483
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
483
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship01:29

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

2.1K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.1K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

2.5K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.5K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

507
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
507
Antihypertensive Drugs: Thiazide-Class Diuretics01:15

Antihypertensive Drugs: Thiazide-Class Diuretics

515
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
515
Aryldiazonium Salts to Azo Dyes: Diazo Coupling01:11

Aryldiazonium Salts to Azo Dyes: Diazo Coupling

2.9K
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the...
2.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Isothiocyanate-Rich Essential Oil of <i>Morisonia flexuosa</i> L. Exhibits Anxiolytic-like Effects That May Involve Serotonergic Pathways in Zebrafish.

Plants (Basel, Switzerland)·2026
Same author

Targeting of Leishmania proteins by β-Lapachone derivatives reveals a promising multitarget candidate.

Archives of microbiology·2026
Same author

Heterocyclic Derivatives in Parkinson's Therapy: Recent Advances and Prospects.

Medicinal chemistry (Shariqah (United Arab Emirates))·2026
Same author

Electron donating and withdrawing groups affect the antioxidant activity of 4'-aminochalcones on gentamicin-induced kidney cell injury.

Biological chemistry·2026
Same author

Plant exosomes as multifunctional platforms for metabolic targeting and drug delivery in cancer therapy.

Biochemical pharmacology·2026
Same author

Ufasomes as Novel Fatty Acid-Based Vesicular Systems for Drug Delivery.

Current pharmaceutical design·2026

相关实验视频

Updated: May 25, 2025

Facile Preparation of 4-Substituted Quinazoline Derivatives
11:51

Facile Preparation of 4-Substituted Quinazoline Derivatives

Published on: February 15, 2016

11.8K

探索林衍生物:它们的抗疟疾功效和结构特征

Raghav Mishra1, Jayze da Cunha Xavier2, Nitin Kumar3

  • 1Department of Pharmacy, Lloyd School of Pharmacy, Knowledge Park II, Greater Noida, Uttar Pradesh 201306, India.

Medicinal chemistry (Shariqah (United Arab Emirates))
|February 26, 2025
PubMed
概括

奎诺林化合物显示出对抗疟疾的希望,有效地向Plasmodium falciparum和Plasmodium vivax. 对它们的结构-活性关系的进一步研究可能会产生新的抗疟疾药物.

关键词:
流感病毒 (Plasmodium) 是一种流感病毒.奎诺林衍生品 奎诺林衍生品这是一种抗疟疾药物.这是排毒.排毒.排毒.疟疾 疟疾 是一种疾病.结构-活动关系关系.

更多相关视频

Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine
08:31

Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine

Published on: October 11, 2019

10.2K
Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
09:13

Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases

Published on: November 22, 2024

1.3K

相关实验视频

Last Updated: May 25, 2025

Facile Preparation of 4-Substituted Quinazoline Derivatives
11:51

Facile Preparation of 4-Substituted Quinazoline Derivatives

Published on: February 15, 2016

11.8K
Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine
08:31

Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine

Published on: October 11, 2019

10.2K
Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
09:13

Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases

Published on: November 22, 2024

1.3K

科学领域:

  • 药用化学 医学化学
  • 寄生虫学的寄生虫学
  • 药物发现 药物发现 药物发现

背景情况:

  • 疟疾仍然是全球主要的死亡原因,迫切需要开发有效的治疗方法.
  • 及时诊断和迅速干预对于管理疟疾的不良影响至关重要.

研究的目的:

  • 审查林基化合物作为抗疟疾药物,重点关注其有效性和结构特征.
  • 探索oline衍生物的治疗潜力和结构-活性关系 (SAR).
  • 确定有效对抗多抗药性Plasmodium falciparum和Plasmodium vivax的化合物.

主要方法:

  • 进行了全面的文献审查.
  • 评估了基诺林抗疟药对P. falciparum和P. vivax的疗效.
  • 分析了这些化合物的作用机制和SAR.

主要成果:

  • 奎诺林抗疟药有效地消除了P. falciparum,特别是在非洲和亚洲.
  • 化合物显示免疫调节特性和耐受性,表明更广泛的适用性.
  • 新衍生物,包括金属基因复合物和混合基因,表现出增强的抗疟疾活性.
  • 机制包括在寄生虫的食物真空中积累和破坏血排毒.
  • 对抗抗克洛洛昆抗性菌株观察到强烈的疗效.

结论:

  • 基于昆的化合物为对抗P. falciparum和P. vivax的疟疾控制提供了一个有希望的策略.
  • 进一步研究SAR和机制可以促进开发优质的抗疟疾疗法.